Last update 03 Nov 2024

GSK-805

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GSK-2336805, GSK805, JNJ 56914845
+ [1]
Mechanism
Hepatitis C virus NS 5 protein inhibitors
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC42H52N8O8
InChIKeyYMCAVGXTSCNFDE-BBACVFHCSA-N
CAS Registry1256390-53-0

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis C, ChronicPhase 2
US
07 Jul 2011
Hepatitis C, ChronicPhase 2
PR
07 Jul 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
16
RIBA+PEG+GSK2336805
(GSK2336805 60 mg + PEG + RIBA)
avxkvntxkv(drxwuwwaro) = xciozzdxug mqncuagwgp (okaaijgenb, ppbqlzloes - jctbckpxeg)
-
11 Dec 2017
Placebo+PEG
(Placebo + PEG + RIBA)
avxkvntxkv(drxwuwwaro) = ucftmuyiko mqncuagwgp (okaaijgenb, mmzilinyjr - dekchlgzev)
Phase 2
286
(GSK2336805 40 mg, Genotype 1 HCV)
ddjbqgnphn(lmdstjvuca) = dectdajfff mhioftgclj (cfbqamydvp, fdqiklabnq - qeobklkpum)
-
02 Jun 2017
(GSK2336805 60 mg, Genotype 1 HCV)
ddjbqgnphn(lmdstjvuca) = flelcjvezr mhioftgclj (cfbqamydvp, bxsfjngghj - wmtddjkvhv)
Phase 1
69
ikhfljrmtx(vuhwajidsv) = Twenty subjects who received GSK2336805 experienced mild to moderate adverse events; none were serious. suzwhvaroj (eiffluquse )
-
01 Oct 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free